Sandy provides strategic advice to Bioqube’s investment team and portfolio companies, contributing to both due diligence and post-investment value creation. Sandy is an executive with over 30 years in the life sciences industry, where he has extensive and deep relationships with pharma senior R&D and business management executives, as well as the investment community.

He has served as CEO or President of five companies, chaired or joined multiple boards, and raised over $750M in capital, while leading numerous M&A and licensing transactions. Sandy currently serves as President and board member of IMIDomics, Chair of Carisma, Executive Chair of Paradox Immunotherapeutics and non-executive board member of Compugen. He has built extensive relationships with senior R&D and business executives, investors, and the broader healthcare community.